Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Follow-Up Study of Oral ELND005 (AZD-103) in Subjects With Alzheimer's Disease

NCT00934050 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00934050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Follow-Up Study of Oral ELND005 (AZD-103) in Subjects With Alzheimer's Disease
Lead sponsor
OPKO Health, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
June 30, 2011
Enrollment
103 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease